Amgen (AMGN) Sets New 52-Week Low on 'denosumab' Results
Go back to Amgen (AMGN) Sets New 52-Week Low on 'denosumab' Results| Amgen Inc (NASDAQ: AMGN) | Delayed: 407.27 -14.24 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $421.51 | 52 Week High | $176.85 | |||
| Open | $421.72 | 52 Week Low | $133.64 | |||
| Day High | $422.80 | P/E | 61.34 | |||
| Day Low | $407.13 | EPS | $6.64 | |||
| Volume | 2,500,546 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 143.81 -1.5 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.31 | 52 Week High | $65.46 | |||
| Open | $144.71 | 52 Week Low | $47.97 | |||
| Day High | $145.39 | P/E | 97.83 | |||
| Day Low | $143.26 | EPS | $1.47 | |||
| Volume | 7,856,229 | |||||
